4//SEC Filing
Ahrens Brenton Karl 4
Accession 0001209191-22-051422
CIK 0001659323other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 6:12 AM ET
Size
5.5 KB
Accession
0001209191-22-051422
Insider Transaction Report
Form 4
Ahrens Brenton Karl
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-09-25$1.59/sh+14,838$23,592→ 14,838 totalExercise: $1.59Exp: 2032-09-24→ Ordinary Shares (14,838 underlying)
Footnotes (1)
- [F1]Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on July 1, 2023.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001322927
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 6:12 AM ET
- Size
- 5.5 KB